August 10, 2026
1 min read

New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval MedNews

MONDAY, Aug. 10, 2026 Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma giving doctors another weapon to fight this

Leave a Reply

Your email address will not be published.

Previous Story

Japan Focus: Asahi’s growth plans, Calbee on personalised nutrition, food tech investment, and more

Next Story

FDA to require notice of additives in food supply for the first time

Previous Story

Japan Focus: Asahi’s growth plans, Calbee on personalised nutrition, food tech investment, and more

Next Story

FDA to require notice of additives in food supply for the first time

Latest from Blog

Go toTop